Sequencing Market is estimated to increase at a growth rate of 20.8% CAGR over the forecast period from 2024 to 2032.
The Sequencing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product & Services (Platform, Consumables), By Application (Oncology (Diagnostics and Screening, Oncology Screening, Companion Diagnostics, Others), Research Studies, Clinical Investigation (Infectious Diseases, Inherited Diseases, Idiopathic Diseases, Non-Communicable/Others), Reproductive Health(NIPT, PGT, Newborn Genetic Screening, Single Gene Analysis), HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, Consumer Genomics), By Workflow (Pre-Sequencing, Sequencing, Data Analysis), By End-User (Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, Others).
An Introduction to Sequencing Market in 2024
The Sequencing Market in 2024 is experiencing a revolutionary phase, fueled by rapid advancements in next-generation sequencing (NGS) technologies and the expanding applications of genomic sequencing across various sectors. With plummeting sequencing costs and improved throughput, NGS has become indispensable in genomics research, clinical diagnostics, and personalized medicine. The market witnesses a surge in demand for high-throughput sequencing platforms, bioinformatics tools, and sequencing services to decode the complexities of the human genome, unravel disease mechanisms, and accelerate drug discovery and development. However, challenges related to data analysis, interpretation, and privacy concerns underscore the need for robust bioinformatics solutions and regulatory frameworks to harness the full potential of genomic sequencing.
Sequencing Market Trend: Adoption of Next-Generation Sequencing (NGS) Technologies Driving Growth in Sequencing Market
A prominent trend in the Sequencing Market is the widespread adoption of next-generation sequencing (NGS) technologies. NGS offers higher throughput, reduced cost per base, and increased speed compared to traditional sequencing methods, enabling researchers to perform large-scale genomic studies with greater efficiency and accuracy. The growing demand for NGS in various applications such as personalized medicine, clinical diagnostics, agriculture, and microbiology is propelling the overall growth of the sequencing market.
Sequencing Market Driver: Advancements in Genomic Research and Precision Medicine Fueling Sequencing Market Expansion
The key driver for the Sequencing Market is the continuous advancements in genomic research and the increasing application of sequencing technologies in precision medicine initiatives. Genomic sequencing plays a critical role in understanding the genetic basis of diseases, identifying biomarkers, and developing targeted therapies tailored to individual patients. As precision medicine gains momentum and becomes an integral part of healthcare, there is a growing need for high-throughput sequencing technologies to decipher the complexities of the human genome, driving the demand for sequencing solutions.
Sequencing Market Opportunity: Expansion of Sequencing Applications in Non-Clinical Fields
An opportunity within the Sequencing Market lies in the expansion of sequencing applications beyond clinical diagnostics to non-clinical fields such as agriculture, environmental science, forensics, and biotechnology. Sequencing technologies offer valuable insights into the genetic diversity of crops, microbial communities, environmental pollutants, and forensic samples, among others. By leveraging sequencing platforms for diverse applications, stakeholders can tap into new markets, diversify revenue streams, and address emerging challenges in various industries, thereby unlocking additional growth opportunities in the sequencing market.
Sequencing Market Segmentation
By Product & Services
Platform
-1st Generation of sequencing device
-2nd Generation of sequencing device
-3rd Generation of sequencing device
Consumables
-Kits
-Reagents
-Accessories
-Services
-Software
By Application
Oncology
-Diagnostics and Screening
-Oncology Screening
-Companion Diagnostics
-Others
Research Studies
Clinical Investigation
-Infectious Diseases
-Inherited Diseases
-Idiopathic Diseases
-Non-Communicable/Other Diseases
Reproductive Health
-NIPT
-PGT
-Newborn Genetic Screening
-Single Gene Analysis
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Agrigenomics & Forensics
Consumer Genomics
By Workflow
- Pre-Sequencing
- Sequencing
- Data Analysis
By End-user
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Others
Geographical Analysis
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Sequencing Market Companies
- Illumina Inc
- F. Hoffman-La Roche Ltd
- QIAGEN
- Thermo Fisher Scientific Inc
- Bio-Rad Laboratories Inc
- Oxford Nanopore Technologies
- PierianDx
- Genomatix GmbH
- DNASTAR Inc
- Perkin Elmer Inc
- Eurofins GATC Biotech GmbH
- BGI
*List not exhautsive
Reasons to Buy the Sequencing Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Sequencing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Sequencing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Sequencing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Sequencing Market Size Outlook, $ Million, 2021 to 2030
3.2 Sequencing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Sequencing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Sequencing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Sequencing Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Sequencing Market Industry
4.2 Key Market Trends in Sequencing Market Industry
4.3 Potential Opportunities in Sequencing Market Industry
4.4 Key Challenges in Sequencing Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Sequencing Market Share by Company
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Sequencing Market Outlook By Segments
7.1 Sequencing Market Outlook by Segments
By Product & Services
Platform
-1st Generation of sequencing device
-2nd Generation of sequencing device
-3rd Generation of sequencing device
Consumables
-Kits
-Reagents
-Accessories
-Services
-Software
By Application
Oncology
-Diagnostics and Screening
-Oncology Screening
-Companion Diagnostics
-Others
Research Studies
Clinical Investigation
-Infectious Diseases
-Inherited Diseases
-Idiopathic Diseases
-Non-Communicable/Other Diseases
Reproductive Health
-NIPT
-PGT
-Newborn Genetic Screening
-Single Gene Analysis
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Agrigenomics & Forensics
Consumer Genomics
By Workflow
Pre-Sequencing
Sequencing
Data Analysis
By End-user
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Others
8 North America Sequencing Market Analysis And Outlook To 2030
8.1 Introduction to North America Sequencing Markets in 2024
8.2 North America Sequencing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Sequencing Market size Outlook by Segments, 2021-2030
By Product & Services
Platform
-1st Generation of sequencing device
-2nd Generation of sequencing device
-3rd Generation of sequencing device
Consumables
-Kits
-Reagents
-Accessories
-Services
-Software
By Application
Oncology
-Diagnostics and Screening
-Oncology Screening
-Companion Diagnostics
-Others
Research Studies
Clinical Investigation
-Infectious Diseases
-Inherited Diseases
-Idiopathic Diseases
-Non-Communicable/Other Diseases
Reproductive Health
-NIPT
-PGT
-Newborn Genetic Screening
-Single Gene Analysis
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Agrigenomics & Forensics
Consumer Genomics
By Workflow
Pre-Sequencing
Sequencing
Data Analysis
By End-user
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Others
9 Europe Sequencing Market Analysis And Outlook To 2030
9.1 Introduction to Europe Sequencing Markets in 2024
9.2 Europe Sequencing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Sequencing Market Size Outlook By Segments, 2021-2030
By Product & Services
Platform
-1st Generation of sequencing device
-2nd Generation of sequencing device
-3rd Generation of sequencing device
Consumables
-Kits
-Reagents
-Accessories
-Services
-Software
By Application
Oncology
-Diagnostics and Screening
-Oncology Screening
-Companion Diagnostics
-Others
Research Studies
Clinical Investigation
-Infectious Diseases
-Inherited Diseases
-Idiopathic Diseases
-Non-Communicable/Other Diseases
Reproductive Health
-NIPT
-PGT
-Newborn Genetic Screening
-Single Gene Analysis
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Agrigenomics & Forensics
Consumer Genomics
By Workflow
Pre-Sequencing
Sequencing
Data Analysis
By End-user
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Others
10 Asia Pacific Sequencing Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Sequencing Markets in 2024
10.2 Asia Pacific Sequencing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Sequencing Market size Outlook by Segments, 2021-2030
By Product & Services
Platform
-1st Generation of sequencing device
-2nd Generation of sequencing device
-3rd Generation of sequencing device
Consumables
-Kits
-Reagents
-Accessories
-Services
-Software
By Application
Oncology
-Diagnostics and Screening
-Oncology Screening
-Companion Diagnostics
-Others
Research Studies
Clinical Investigation
-Infectious Diseases
-Inherited Diseases
-Idiopathic Diseases
-Non-Communicable/Other Diseases
Reproductive Health
-NIPT
-PGT
-Newborn Genetic Screening
-Single Gene Analysis
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Agrigenomics & Forensics
Consumer Genomics
By Workflow
Pre-Sequencing
Sequencing
Data Analysis
By End-user
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Others
11 South America Sequencing Market Analysis And Outlook To 2030
11.1 Introduction to South America Sequencing Markets in 2024
11.2 South America Sequencing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Sequencing Market size Outlook by Segments, 2021-2030
By Product & Services
Platform
-1st Generation of sequencing device
-2nd Generation of sequencing device
-3rd Generation of sequencing device
Consumables
-Kits
-Reagents
-Accessories
-Services
-Software
By Application
Oncology
-Diagnostics and Screening
-Oncology Screening
-Companion Diagnostics
-Others
Research Studies
Clinical Investigation
-Infectious Diseases
-Inherited Diseases
-Idiopathic Diseases
-Non-Communicable/Other Diseases
Reproductive Health
-NIPT
-PGT
-Newborn Genetic Screening
-Single Gene Analysis
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Agrigenomics & Forensics
Consumer Genomics
By Workflow
Pre-Sequencing
Sequencing
Data Analysis
By End-user
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Others
12 Middle East And Africa Sequencing Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Sequencing Markets in 2024
12.2 Middle East and Africa Sequencing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Sequencing Market size Outlook by Segments, 2021-2030
By Product & Services
Platform
-1st Generation of sequencing device
-2nd Generation of sequencing device
-3rd Generation of sequencing device
Consumables
-Kits
-Reagents
-Accessories
-Services
-Software
By Application
Oncology
-Diagnostics and Screening
-Oncology Screening
-Companion Diagnostics
-Others
Research Studies
Clinical Investigation
-Infectious Diseases
-Inherited Diseases
-Idiopathic Diseases
-Non-Communicable/Other Diseases
Reproductive Health
-NIPT
-PGT
-Newborn Genetic Screening
-Single Gene Analysis
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Agrigenomics & Forensics
Consumer Genomics
By Workflow
Pre-Sequencing
Sequencing
Data Analysis
By End-user
Academic Research
Clinical Research
Hospitals & Clinics
Pharma & Biotech Entities
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Illumina Inc
F. Hoffman-La Roche Ltd
QIAGEN
Thermo Fisher Scientific Inc
Bio-Rad Laboratories Inc
Oxford Nanopore Technologies
PierianDx
Genomatix GmbH
DNASTAR Inc
Perkin Elmer Inc
Eurofins GATC Biotech GmbH
BGI
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
Sequencing Market Segmentation
By Product & Services
Platform
-1st Generation of sequencing device
-2nd Generation of sequencing device
-3rd Generation of sequencing device
Consumables
-Kits
-Reagents
-Accessories
-Services
-Software
By Application
Oncology
-Diagnostics and Screening
-Oncology Screening
-Companion Diagnostics
-Others
Research Studies
Clinical Investigation
-Infectious Diseases
-Inherited Diseases
-Idiopathic Diseases
-Non-Communicable/Other Diseases
Reproductive Health
-NIPT
-PGT
-Newborn Genetic Screening
-Single Gene Analysis
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Agrigenomics & Forensics
Consumer Genomics
By Workflow
- Pre-Sequencing
- Sequencing
- Data Analysis
By End-user
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Others
Geographical Analysis
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
